Delivery Order SPE2DB24D2013-SPE2DB25FCJDK

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REYVOW 100 MG TABLET UD 8S. The award, valued at $1,473.87, is a firm fixed-price delivery order contract with an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The award has a ceiling value of $1,061.36 and an ultimate completion date of September 19, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Reyvow (100 mg tablet) and has a ceiling value of $1,527.15. It is a firm fixed-price contract with an ultimate completion date of May 12, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a ceiling value of $1,549.05 and a performance period ending on May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is a delivery order worth $1,020.98 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.31 firm fixed-price delivery order is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has a completion date of July 8, 2022 and was awarded on July 7, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,226.28, is for the delivery of 4565008275 REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,729.58, is for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
This is a $1,466.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REYVOW 100 MG TABLET UD 8S, a prescription medication. The award has an ultimate completion date of November 6, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,421.88, is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract is for the supply of REYVOW 100 MG TABLET UD 8S, a prescription medication, to...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCJDK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of REYVOW 50 MG TABLET UD 8S. The delivery order, with a ceiling value of $1,094.01, is a firm fixed price contract with a completion date of May 13, 2025.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The delivery order for REYVOW 50 MG TABLET UD 8S is not designated as a set-aside contract.

Generated 8/17/25, 1:07 AM